-
28TH NOVEMBER: CURRENT CHALLENGES IN CLINICAL TRIALS
Lung Cancer Europe will hold an event on 28th November at the EU Parliament to highlight the current challenges in clinical trials across Europe Within the…
-
NOVEMBER IS LUNG CANCER AWARENESS MONTH
According to Globocan 2018, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause…
-
BEING HEARD OVER THE NOISE
LuCE president, Stefania Vallone provided an insight analysis on “Being heard over the noise: The patient viewpoint” during #ESMO2018. She emphasized the role can patients…
-
LUCE STAND AT ESMO 2018
We invite all interested ESMO members to visit us @LuCE booth located in the society village at ESMO 2018 in Munich. Name: LuCEHall: B1Stand: PA 8 LuCE…
-
NEW GLOBOCAN STATISTICS PLACED LUNG CANCER AS THE MOST FREQUENT CANCER AND THE LEADING CAUSE OF CANCER DEATH AMONG MALES
According to tthe new statistics, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6 % of the total cases) and the…
-
#WCLC2018 CONCLUSIONS – STRATEGIES TO MAXIMIZE THE CLINICAL BENEFIT OF EGFR TKIS IN ADVANCED NSCLC
During the congress, one of the topics covered focused on the importance of EGFR TKIs in Advanced NSCLC. Apply expert recommendations for frontline therapy for…
-
#WCLC2018 CONCLUSIONS – NELSON STUDY SHOWS CT SCREENING FOR NODULE VOLUME MANAGEMENT REDUCES LUNG CANCER MORTALITY BY 26 PERCENT IN MEN
During the World Congress on Lung Cancer held this year in Toronto, Canada were presented the findings of NELSON study. These demonstrate that the use…
-
LUNG CANCER EUROPE IS GROWING STRONGER
Starting September, Alfonso Aguarón (second from left) is LuCE’s new project manager. He has extensive experience in patient advocacy field as Hodgkin’s Lymphoma survivor. This…
-
NEW ESMO TUMOUR DNA SCALE HELPS MATCH PATIENTS WITH CANCER TO OPTIMAL TARGETED MEDICINES
A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by leading cancer specialists in Europe…